Ringing in the New Year As we slowly emerge from the pandemic, we are beginning to see a bright spot in the future of the life sciences industry and wider global economy. From what I can gather, there is a collective and anticipatory sigh of relief that this will all...
WHO + WHY? Looking back at M+A activity this year, I took notice of a few that stood out, irrespective of their size. Over the past 12 months, companies have experienced an increase in IPOs. However, if this was used as their exit strategy, it means M+A is down....
The Demand for Talent To state the obvious, the pandemic has brought about tremendous change across the global landscape. The most glaring impact in my world, brokering in executive level talent in financial services, has been the massive demand for talent, and the...
THE GREAT RESIGNATION: WHAT THE FUTURE HOLDS FOR TODAY’S JOB MARKET We hear it day in and day out — it’s so hard to find talent in this market! Oftentimes, the concept of finding “the perfect fit” stands in the way of a company making the best hiring decision, and not...
TRANSITIONING TO A HYBRID WORKFORCE IN LIFE SCIENCES As we begin to re-enter a normalized version of the past 16 months, the transition from fully remote workforces to new working environments is nearly upon us. I have heard everything from Life Sciences companies...
Perhaps unexpected with the healthcare crisis, our Technology + Life Science Practice doubled in 2020, and we are on track to repeat this performance in 2021. By the end of May, my team had closed the first five months of 2021 at a revenue higher than all of 2020. In...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policy
